Cost analysis of rapid diagnostics for drug-resistant tuberculosis-Reference-Cited by-同舟云学术

Cost analysis of rapid diagnostics for drug-resistant tuberculosis

Published:2018-03-02 Issue:1 Volume:18 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Groessl Erik J.^ORCID,Ganiats Theodore G.,Hillery Naomi,Trollip Andre,Jackson Roberta L.,Catanzaro Donald G.,Rodwell Timothy C.,Garfein Richard S.,Rodrigues Camilla,Crudu Valeriu,Victor Thomas C.,Catanzaro Antonino

Funder

NIH

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-018-3013-0.pdf

Reference31 articles.

1. World Health Organization (WHO): Global tuberculosis report 2013. 2013.

2. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603–62.

3. Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, Gandhi NR. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS One. 2010;5(12):e15735.

4. Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, Masotla T, van der Walt M, Pagano M, Jensen P, Nardell E. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(9):1019–25.

5. Engstrom A, Morcillo N, Imperiale B, Hoffner SE, Jureen P. Detection of first- and second-line drug resistance in mycobacterium tuberculosis clinical isolates by pyrosequencing. J Clin Microbiol. 2012;50(6):2026–33.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on cost-effectiveness of diagnostic methods and treatments for tuberculosis in India;Indian Journal of Tuberculosis;2024-04

2. To Test or Not? Xpert MTB/RIF as an Alternative to Smear Microscopy to Guide Line Probe Assay Testing for Drug-Resistant Tuberculosis;Journal of Clinical Microbiology;2023-07-20

3. A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings;The International Journal of Tuberculosis and Lung Disease;2023-05-01

4. Association Between Pain and Sarcopenia Among Adults Aged ≥65 Years from Low- and Middle-Income Countries;The Journals of Gerontology: Series A;2023-01-05

5. Frequent Suboptimal Thermocycler Ramp Rate Usage Negatively Impacts GenoType MTBDRsl VER 2.0 Performance for Second-Line Drug-Resistant Tuberculosis Diagnosis;The Journal of Molecular Diagnostics;2022-05